Nrf2–ARE pathway: an emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases
Neurodegenerative diseases (NDDs) are predicted to be the biggest health concern in this
century and the second leading cause of death by 2050. The main risk factor of these …
century and the second leading cause of death by 2050. The main risk factor of these …
Pluripotent stem cells progressing to the clinic
A Trounson, ND DeWitt - Nature reviews Molecular cell biology, 2016 - nature.com
Basic experimental stem cell research has opened up the possibility of many diverse clinical
applications; however, translation to clinical trials has been restricted to only a few diseases …
applications; however, translation to clinical trials has been restricted to only a few diseases …
When it comes to an end: oxidative stress crosstalk with protein aggregation and neuroinflammation induce neurodegeneration
P Michalska, R León - Antioxidants, 2020 - mdpi.com
Neurodegenerative diseases are characterized by a progressive loss of neurons in the brain
or spinal cord that leads to a loss of function of the affected areas. The lack of effective …
or spinal cord that leads to a loss of function of the affected areas. The lack of effective …
Nrf2/ARE signaling pathway: key mediator in oxidative stress and potential therapeutic target in ALS
Nrf2 (nuclear erythroid 2‐related factor 2) is a basic region leucine‐zipper transcription
factor which binds to the antioxidant response element (ARE) and thereby regulates the …
factor which binds to the antioxidant response element (ARE) and thereby regulates the …
Motoneuron loss is associated with sarcopenia
M Drey, B Krieger, CC Sieber, JM Bauer… - Journal of the American …, 2014 - Elsevier
Objectives Sarcopenia, age-related muscle wasting, is associated with increased morbidity
and mortality in the affected individuals. The pathogenesis of sarcopenia is not yet fully …
and mortality in the affected individuals. The pathogenesis of sarcopenia is not yet fully …
Changing paradigm to target microglia in neurodegenerative diseases: from anti-inflammatory strategy to active immunomodulation
E Pena-Altamira, F Prati, F Massenzio… - Expert opinion on …, 2016 - Taylor & Francis
Introduction: The importance of microglia in most neurodegenerative pathologies, from
Parkinson's disease to amyotrophic lateral sclerosis and Alzheimer's disease, is increasingly …
Parkinson's disease to amyotrophic lateral sclerosis and Alzheimer's disease, is increasingly …
Therapeutic progress in amyotrophic lateral sclerosis-beginning to learning
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease associated with
motor neuron degeneration, muscle weakness, paralysis and finally death. The proposed …
motor neuron degeneration, muscle weakness, paralysis and finally death. The proposed …
Current therapy of drugs in amyotrophic lateral sclerosis
H Lu, WD Le, YY Xie, XP Wang - Current neuropharmacology, 2016 - ingentaconnect.com
Amyotrophic lateral sclerosis (ALS), commonly termed as motor neuron disease (MND) in
UK, is a chronically lethal disorder among the neurodegenerative diseases, meanwhile. ALS …
UK, is a chronically lethal disorder among the neurodegenerative diseases, meanwhile. ALS …
[HTML][HTML] Plant-derived natural compounds for the treatment of amyotrophic lateral sclerosis: an update
Background Amyotrophic lateral sclerosis (ALS) is a motor neuron disease (MND) that
typically causes death within 3-5 years after diagnosis. Regardless of the substantial …
typically causes death within 3-5 years after diagnosis. Regardless of the substantial …
Simple biological systems for assessing the activity of superoxide dismutase mimics
Significance: Half a century of research provided unambiguous proof that superoxide and
species derived from it—reactive oxygen species (ROS)—play a central role in many …
species derived from it—reactive oxygen species (ROS)—play a central role in many …